High Dose News Today

Intermediary results of high dose PDC*lung01 combined with pembrolizumab show mild safety profile, immunological activity and promising tumor response in Non-Small Cell Lung Cancer patientsCombination of high dose PDC*lung01 with pembrolizumab in 19 evaluable patients resulted in objective response rate of 63.2% and...

LIÈGE, Belgium & GRENOBLE, France, April 08, 2024--PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the interim results from the last cohort of patients in its phase I/II clinical trial (PDC-LUNG-101, NCT03970746) with PDC*lung01.

Fish oil is rich in omega-3 fatty acids, which are beneficial for brain, heart, and immune health—but kids don't always get enough from diet. These are the 8 best fish oil supplements for kids, according to pediatric nutrition experts.

The Marion County Health Department is fighting the flu by encouraging people to get a flu vaccine. And they are offering a flu clinic in order to make it happen. “The Marion County Health Department has made getting a flu shot more accessible by holding vaccination clinics throughout Marion Coun

New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on... | May 25, 2023

New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on

MG Comet EV is solution for most of the mobility challenges that we face in our day-to-day life. You can find more about it in our extensive review

/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsungs Byooviz and...

/PRNewswire/ -- Ophthalmologists saw the entry of the first biosimilars into the armamentarium in 2022 with the launch of Biogen and Samsungs Byooviz and...

Gurugram (Haryana) [India], December 27 (ANI/BusinessWire India): India is now facing a significant burden from the rising cancer incidence rate, which is continually climbing. According to estimates, India will record 19 to 20 lakh cancer cases by the end of 2022, although the actual incidence is 1.5 to 3 times higher, a lot of which goes undocumented. In 2020, the combined age-standardised rate for all cancers, excluding non-melanoma skin cancer, was 190 per 100,000, and men had a greater rate...